ClinicalTrials.Veeva

Menu

An Observational Study to Evaluate Safety, Performance, and Clinical Benefit of BeFlow

B

Bentley InnoMed

Status

Enrolling

Conditions

Iliac Artery Occlusion
Iliac Artery Stenosis

Treatments

Device: Stenting

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT07010354
PM15-01 BeFlow

Details and patient eligibility

About

This international, observational multi-centre study of the device BFI will monitor technical success of the implantation, data regarding clinical performance, clinical benefit, as well as potential unknown side effects pursuant to the Intended Purpose.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with an indication for permanent intraluminal placement in iliac arteries for restoring and improving the patency impaired by arteriosclerosis or other stenoses that may be treated by stenting according to the IFU of the BFI
  • Patient is capable and willing to sign an informed consent
  • Patients ≥18 years of age at the time of consent

Exclusion criteria

  • Patients with any contraindication according to the IFU
  • Previous stenting of the target vessel

Trial contacts and locations

2

Loading...

Central trial contact

Richard A Griesbach, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems